Pardoprunox
Code | Size | Price |
---|
TAR-T1769-5mg | 5mg | £369.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T1769-10mg | 10mg | £490.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T1769-25mg | 25mg | £783.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Pardoprunox is a partial dopamine D2 agonist and noradrenergic agonist with serotonin 5-HT1A agonist properties. Pardoprunox has been used in trials studying the treatment of Early Stage Parkinson's Disease and Advanced Stage Parkinson's Disease.
CAS:
269718-84-5
Formula:
C12H15N3O2
Molecular Weight:
233.271
Pathway:
Neuroscience; GPCR/G Protein
Purity:
0.98
SMILES:
CN1CCN(CC1)c1cccc2[nH]c(=O)oc12
Target:
Dopamine Receptor; 5-HT Receptor; Adrenergic Receptor
References
1. Glennon JC, et al. Synapse. 2006 Dec 15;60(8):599-608.